Arthritis Drug

  • Vanderbilt University

    Research Snapshot: BME team demonstrates potential for 1st clinically successful osteoarthritis drug

    THE IDEA Post-traumatic osteoarthritis—caused by degraded cartilage that cushions the ends of bones in joints—occurs after a joint injury. With the knowledge that PTOA will lead to earlier onset and faster progression of osteoarthritis following an injury, researchers including Craig Duvall, Cornelius Vanderbilt Professor of Engineering, set out to develop… Read More

    Sep. 2, 2021

  • Vanderbilt University

    Arthritis drug could be first to stop heart valve calcification

    The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis. Today in Circulation, the journal of the American Heart Association, Vanderbilt University researchers published findings that the drug – a monoclonal antibody known as SYN0012 – shows promise in keeping heart valve leaflets… Read More

    Jun. 13, 2017